European Patent Office

T 0451/99 (Synthetic antigens/GENETIC SYSTEMS) du 14.03.2003

Identifiant européen de la jurisprudence
ECLI:EP:BA:2003:T045199.20030314
Date de la décision
14 mars 2003
Numéro de l'affaire
T 0451/99
Requête en révision de
-
Numéro de la demande
86902998.3
Classe de la CIB
C12Q 1/70
Langue de la procédure
Anglais
Distribution
Distribuées aux présidents des chambres de recours (C)
Téléchargement
Décision en anglais
Résumés pour cette décision
-
Titre de la demande
Synthetic antigens for the detection of AIDS-related disease
Nom du demandeur
GENETIC SYSTEMS CORPORATION
Nom de l'opposant
Dade Behring Marburg GmbH
Roche Diagnostics GmbH
Chambre
3.3.04
Sommaire

The following questions are referred to the Enlarged Board of Appeal:

Is the introduction into a claim of a disclaimer not supported by the application as filed admissible, and therefore the claim allowable under Article 123(2) EPC, when the purpose of the disclaimer is to meet a lack-of-novelty objection pursuant to Article 54(3) EPC?

If yes, what are the criteria to be applied in assessing the admissibility of the disclaimer?

Mots-clés
Allowability of disclaimers - under Article 123(2) EPC - delimitation against Article 54(3) EPC prior art - criteria to be applied - referral to Enlarged Board of Appeal
Exergue
-

ORDER

For these reasons it is decided that:

The following questions are referred to the Enlarged Board of Appeal:

Is the introduction into a claim of a disclaimer not supported by the application as filed admissible, and therefore the claim allowable under Article 123(2) EPC, when the purpose of the disclaimer is to meet a lack-of-novelty objection pursuant to Article 54(3) EPC?

If yes, what are the criteria to be applied in assessing the admissibility of the disclaimer?